← Back to Search

Acceptance and Commitment Therapy for Chronic Post-Surgical Pain

N/A
Recruiting
Led By Christine B. Sieberg
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Must not have
Inability to speak sufficient English or another language that can be interpreted orally and for questionnaires with the research team
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial will help researchers understand more about chronic post-surgical pain, provide a way to measure it, and understand how age affects it.

Who is the study for?
This trial is for males and females aged 12 or older who have had surgery at least 6 months ago and are experiencing chronic pain that has lasted for more than 3 months post-surgery. Participants must be able to communicate in English or a language the research team can interpret. Those with severe cognitive impairments, significant psychiatric disorders, or illegal hard drug use are excluded.
What is being tested?
The study aims to understand the psychophysical and neural mechanisms of chronic post-surgical pain (CPSP) across different ages. It will evaluate how Acceptance and Commitment Therapy may influence CPSP by examining neurobiological factors, providing metrics for patient follow-up, predicting chronification risks, and exploring age-related differences.
What are the potential side effects?
Since this trial involves Acceptance and Commitment Therapy—a psychological intervention rather than medication—traditional side effects like those seen with drugs are not expected. However, participants might experience emotional discomfort when discussing painful experiences.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I cannot communicate effectively in English or any language the research team understands.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain acceptance using the Chronic Pain Acceptance Questionnaire - Revised (CPAQ-R)
Secondary study objectives
Functional brain metrics using fNIRS

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: ACT Group InterventionActive Control1 Intervention
We will evaluate the effects of an Acceptance and Commitment Therapy (ACT) one-day group intervention (with 1-month post group zoom booster session) on the functional near-infrared spectroscopy (fNIRS) signal in groups of adolescents and adult patients diagnosed with CPSP at \>3 months post major orthopedic surgery.
Group II: Treatment as UsualActive Control1 Intervention
Treatment as Usual (TAU) for those with CPSP

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
3,026 Previous Clinical Trials
13,413,679 Total Patients Enrolled
Boston Children's HospitalLead Sponsor
789 Previous Clinical Trials
5,582,796 Total Patients Enrolled
Christine B. SiebergPrincipal InvestigatorMassachusetts General Hospital

Media Library

ACT Group Intervention Clinical Trial Eligibility Overview. Trial Name: NCT05304286 — N/A
Chronic Postsurgical Pain Research Study Groups: ACT Group Intervention, Treatment as Usual
Chronic Postsurgical Pain Clinical Trial 2023: ACT Group Intervention Highlights & Side Effects. Trial Name: NCT05304286 — N/A
ACT Group Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05304286 — N/A
~40 spots leftby Jun 2026